[PHARMA] YoY TTM Result on 31-Mar-2020 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-May-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Mar-2020 [#1]
Profit Trend
QoQ- 1.86%
YoY- -429.08%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 3,428,957 4,983,690 2,698,649 2,854,343 2,553,141 2,323,589 2,248,121 7.28%
PBT -609,092 282,990 36,437 -191,228 71,756 73,994 73,256 -
Tax -22,048 -104,757 -9,755 44,548 -26,467 -20,676 -26,609 -3.08%
NP -631,140 178,233 26,682 -146,680 45,289 53,318 46,647 -
-
NP to SH -632,403 176,748 28,226 -146,437 44,499 52,386 46,143 -
-
Tax Rate - 37.02% 26.77% - 36.88% 27.94% 36.32% -
Total Cost 4,060,097 4,805,457 2,671,967 3,001,023 2,507,852 2,270,271 2,201,474 10.73%
-
Net Worth -142,812 413,947 355,919 350,047 528,825 524,838 544,360 -
Dividend
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Div 14,409 121,759 23,534 22,188 44,226 51,913 41,456 -16.14%
Div Payout % 0.00% 68.89% 83.38% 0.00% 99.39% 99.10% 89.84% -
Equity
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Net Worth -142,812 413,947 355,919 350,047 528,825 524,838 544,360 -
NOSH 1,310,208 1,309,126 261,705 261,229 260,505 259,821 259,219 30.98%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -18.41% 3.58% 0.99% -5.14% 1.77% 2.29% 2.07% -
ROE 0.00% 42.70% 7.93% -41.83% 8.41% 9.98% 8.48% -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
RPS 261.71 380.45 1,031.18 1,092.66 980.07 894.30 867.27 -18.09%
EPS -48.27 13.49 10.79 -56.06 17.08 20.16 17.80 -
DPS 1.10 9.30 9.00 8.50 17.00 20.00 16.00 -35.98%
NAPS -0.109 0.316 1.36 1.34 2.03 2.02 2.10 -
Adjusted Per Share Value based on latest NOSH - 261,229
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
RPS 237.91 345.79 187.24 198.05 177.15 161.22 155.98 7.28%
EPS -43.88 12.26 1.96 -10.16 3.09 3.63 3.20 -
DPS 1.00 8.45 1.63 1.54 3.07 3.60 2.88 -16.15%
NAPS -0.0991 0.2872 0.247 0.2429 0.3669 0.3642 0.3777 -
Price Multiplier on Financial Quarter End Date
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Date 31/03/23 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 31/03/17 -
Price 0.285 0.755 3.26 1.26 2.27 4.28 4.89 -
P/RPS 0.11 0.20 0.32 0.12 0.23 0.48 0.56 -23.74%
P/EPS -0.59 5.60 30.23 -2.25 13.29 21.23 27.47 -
EY -169.36 17.87 3.31 -44.49 7.53 4.71 3.64 -
DY 3.86 12.32 2.76 6.75 7.49 4.67 3.27 2.80%
P/NAPS 0.00 2.39 2.40 0.94 1.12 2.12 2.33 -
Price Multiplier on Announcement Date
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Date 18/05/23 20/05/22 21/05/21 19/05/20 16/05/19 16/05/18 16/05/17 -
Price 0.38 0.72 4.03 1.88 2.36 4.07 4.72 -
P/RPS 0.15 0.19 0.39 0.17 0.24 0.46 0.54 -19.21%
P/EPS -0.79 5.34 37.37 -3.35 13.82 20.19 26.52 -
EY -127.02 18.74 2.68 -29.82 7.24 4.95 3.77 -
DY 2.89 12.92 2.23 4.52 7.20 4.91 3.39 -2.62%
P/NAPS 0.00 2.28 2.96 1.40 1.16 2.01 2.25 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment